Metlife Stock Current Valuation
| MET Stock | USD 72.72 0.50 0.69% |
Valuation analysis of MetLife helps investors to measure MetLife's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, MetLife's Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 21.48 in 2024, whereas Enterprise Value is likely to drop slightly above 32.5 B in 2024. Fundamental drivers impacting MetLife's valuation include:
Price Book 1.6896 | Enterprise Value 71.8 B | Price Sales 0.758 | Forward PE 7.9745 | Trailing PE 39.9006 |
Fairly Valued
Today
Please note that MetLife's price fluctuation is very steady at this time. Calculation of the real value of MetLife is based on 3 months time horizon. Increasing MetLife's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for MetLife is useful when determining the fair value of the MetLife stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of MetLife. Since MetLife is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MetLife Stock. However, MetLife's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 72.72 | Real 74.79 | Target 78.5 | Hype 72.7 | Naive 72.32 |
The real value of MetLife Stock, also known as its intrinsic value, is the underlying worth of MetLife Company, which is reflected in its stock price. It is based on MetLife's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of MetLife's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence MetLife's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of MetLife helps investors to forecast how MetLife stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MetLife more accurately as focusing exclusively on MetLife's fundamentals will not take into account other important factors: MetLife Company Current Valuation Analysis
MetLife's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current MetLife Current Valuation | 71.8 B |
Most of MetLife's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MetLife is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
MetLife Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for MetLife is extremely important. It helps to project a fair market value of MetLife Stock properly, considering its historical fundamentals such as Current Valuation. Since MetLife's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MetLife's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MetLife's interrelated accounts and indicators.
Click cells to compare fundamentals
MetLife Current Valuation Historical Pattern
Today, most investors in MetLife Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MetLife's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of MetLife current valuation as a starting point in their analysis.
MetLife Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, MetLife has a Current Valuation of 71.8 B. This is 118.78% higher than that of the Insurance sector and significantly higher than that of the Financials industry. The current valuation for all United States stocks is significantly lower than that of the firm.
MetLife Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MetLife's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MetLife could also be used in its relative valuation, which is a method of valuing MetLife by comparing valuation metrics of similar companies.MetLife is currently under evaluation in current valuation category among related companies.
MetLife ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, MetLife's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to MetLife's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
MetLife Fundamentals
| Return On Equity | 0.0531 | |||
| Return On Asset | 0.003 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 71.8 B | |||
| Shares Outstanding | 723.02 M | |||
| Shares Owned By Insiders | 16.40 % | |||
| Shares Owned By Institutions | 75.94 % | |||
| Number Of Shares Shorted | 7.36 M | |||
| Price To Earning | 28.61 X | |||
| Price To Book | 1.69 X | |||
| Price To Sales | 0.76 X | |||
| Revenue | 66.41 B | |||
| Gross Profit | 14.89 B | |||
| EBITDA | 2.36 B | |||
| Net Income | 1.6 B | |||
| Cash And Equivalents | 20.2 B | |||
| Cash Per Share | 41.28 X | |||
| Total Debt | 18.83 B | |||
| Debt To Equity | 4.11 % | |||
| Current Ratio | 1.11 X | |||
| Book Value Per Share | 41.07 X | |||
| Cash Flow From Operations | 13.72 B | |||
| Short Ratio | 2.30 X | |||
| Earnings Per Share | 1.81 X | |||
| Price To Earnings To Growth | 0.11 X | |||
| Target Price | 85.03 | |||
| Number Of Employees | 45 K | |||
| Beta | 1.03 | |||
| Market Capitalization | 52.22 B | |||
| Total Asset | 687.58 B | |||
| Retained Earnings | 40.15 B | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 3.58 % | |||
| Net Asset | 687.58 B | |||
| Last Dividend Paid | 2.06 |
About MetLife Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MetLife's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MetLife using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MetLife based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out MetLife Piotroski F Score and MetLife Altman Z Score analysis. For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.Note that the MetLife information on this page should be used as a complementary analysis to other MetLife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for MetLife Stock analysis
When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is MetLife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetLife. If investors know MetLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MetLife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Dividend Share 2.06 | Earnings Share 1.81 | Revenue Per Share 88.295 | Quarterly Revenue Growth 0.219 |
The market value of MetLife is measured differently than its book value, which is the value of MetLife that is recorded on the company's balance sheet. Investors also form their own opinion of MetLife's value that differs from its market value or its book value, called intrinsic value, which is MetLife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MetLife's market value can be influenced by many factors that don't directly affect MetLife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MetLife's value and its price as these two are different measures arrived at by different means. Investors typically determine if MetLife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MetLife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.